A Safety and Efficacy Study to Evaluate Wound Healing

• Status: Completed
• Trial end date: 2019-12-19
• Target enrollment: 0
• Participant gender: All

Summary

To evaluate the safety, efficacy and pharmacokinetic profile of ascending concentrations of the study medication compared with vehicle in subjects with incisional wounds

• Phase: Phase 1/Phase 2
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Aiviva BioPharma Inc.; AiViva BioPharma, Inc.

Criteria

Inclusion Criteria:

• Eligible for an abdominoplasty

• Nonsmoker

• Fitzpatrick I-IV

• Weight >45Kg

• BMI <= 35

Exclusion Criteria:

• Existing scars in study area, active infection

• Any medical history or present conditions that may increase the risk associated with study participation or investigational product administration and, in the judgment of the Investigator, would make the subject inappropriate for entry into this study